Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.

Antroula Papakonstantinou; Elham Hedayati; Mats Hellström; Hemming Johansson; Michael Gnant; Günther Steger; Richard Greil; Michael Untch; Volker Moebus; Sibylle Loibl; Theodoros Foukakis; Jonas Bergh; Alexios Matikas

doi:10.1080/0284186X.2019.1670353

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.

Antroula Papakonstantinou, Elham Hedayati, Mats Hellström, Hemming Johansson, Michael Gnant, Günther Steger, Richard Greil (Co-author), Michael Untch, Volker Moebus, Sibylle Loibl, Theodoros Foukakis, Jonas Bergh, Alexios Matikas

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	75-81
Journal	ACTA ONCOLOGICA
Volume	59
Issue number	1
DOIs	https://doi.org/10.1080/0284186X.2019.1670353
Publication status	Published - 2020

Keywords

COLONY-STIMULATING FACTOR
PATIENTS RECEIVING CHEMOTHERAPY
FEBRILE NEUTROPENIA
COST-EFFECTIVENESS
CLINICAL-PRACTICE
SECONDARY PROPHYLAXIS
G-CSF
PEGFILGRASTIM
FILGRASTIM
INTENSITY

Access to Document

10.1080/0284186X.2019.1670353

Cite this

Papakonstantinou, A., Hedayati, E., Hellström, M., Johansson, H., Gnant, M., Steger, G., Greil, R., Untch, M., Moebus, V., Loibl, S., Foukakis, T., Bergh, J., & Matikas, A. (2020). Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer. ACTA ONCOLOGICA , 59(1), 75-81. https://doi.org/10.1080/0284186X.2019.1670353

Papakonstantinou, Antroula ; Hedayati, Elham ; Hellström, Mats et al. / Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer. In: ACTA ONCOLOGICA 2020 ; Vol. 59, No. 1. pp. 75-81.

@article{13ac6a5791c94221b7a938e417017e0f,

title = "Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.",

keywords = "COLONY-STIMULATING FACTOR, PATIENTS RECEIVING CHEMOTHERAPY, FEBRILE NEUTROPENIA, COST-EFFECTIVENESS, CLINICAL-PRACTICE, SECONDARY PROPHYLAXIS, G-CSF, PEGFILGRASTIM, FILGRASTIM, INTENSITY",

author = "Antroula Papakonstantinou and Elham Hedayati and Mats Hellstr{\"o}m and Hemming Johansson and Michael Gnant and G{\"u}nther Steger and Richard Greil and Michael Untch and Volker Moebus and Sibylle Loibl and Theodoros Foukakis and Jonas Bergh and Alexios Matikas",

note = "Greil: IIIrdMedical Department, Cancer Cluster Salzburg, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg,Salzburg, Austria;",

year = "2020",

doi = "10.1080/0284186X.2019.1670353",

language = "English",

volume = "59",

pages = "75--81",

journal = "ACTA ONCOLOGICA ",

issn = "0284-186X",

number = "1",

}

Papakonstantinou, A, Hedayati, E, Hellström, M, Johansson, H, Gnant, M, Steger, G, Greil, R, Untch, M, Moebus, V, Loibl, S, Foukakis, T, Bergh, J & Matikas, A 2020, 'Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.', ACTA ONCOLOGICA , vol. 59, no. 1, pp. 75-81. https://doi.org/10.1080/0284186X.2019.1670353

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer. / Papakonstantinou, Antroula; Hedayati, Elham; Hellström, Mats et al.
In: ACTA ONCOLOGICA , Vol. 59, No. 1, 2020, p. 75-81.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.

AU - Papakonstantinou, Antroula

AU - Hedayati, Elham

AU - Hellström, Mats

AU - Johansson, Hemming

AU - Gnant, Michael

AU - Steger, Günther

AU - Greil, Richard

AU - Untch, Michael

AU - Moebus, Volker

AU - Loibl, Sibylle

AU - Foukakis, Theodoros

AU - Bergh, Jonas

AU - Matikas, Alexios

N1 - Greil: IIIrdMedical Department, Cancer Cluster Salzburg, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg,Salzburg, Austria;

PY - 2020

Y1 - 2020

KW - COLONY-STIMULATING FACTOR

KW - PATIENTS RECEIVING CHEMOTHERAPY

KW - FEBRILE NEUTROPENIA

KW - COST-EFFECTIVENESS

KW - CLINICAL-PRACTICE

KW - SECONDARY PROPHYLAXIS

KW - G-CSF

KW - PEGFILGRASTIM

KW - FILGRASTIM

KW - INTENSITY

U2 - 10.1080/0284186X.2019.1670353

DO - 10.1080/0284186X.2019.1670353

M3 - Original Article (Journal)

C2 - 31583943

SN - 0284-186X

VL - 59

SP - 75

EP - 81

JO - ACTA ONCOLOGICA

JF - ACTA ONCOLOGICA

IS - 1

ER -

Papakonstantinou A, Hedayati E, Hellström M, Johansson H, Gnant M, Steger G et al. Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer. ACTA ONCOLOGICA . 2020;59(1):75-81. doi: 10.1080/0284186X.2019.1670353